Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael A Laffan

Showing results (11-20 of 51) with videos related to

Pageof 6
Sort By:
British Journal of Haematology|February 14, 2002
Genotype at the secretor blood group locus is a determinant of plasma von Willebrand factor levelJames O'Donnell, Frank E Boulton, Richard A Manning, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|September 22, 2005
Low-density lipoprotein receptor-related protein polymorphisms in patients with elevated factor VIII coagulant activity and venous thrombosisNicholas Cunningham, Michael A Laffan, Richard A Manning, et al.
Blood|April 21, 2016
Inherited platelet disorders: toward DNA-based diagnosisClaire Lentaigne, Kathleen Freson, Michael A Laffan, et al.
Journal of Thrombosis and Haemostasis : JTH|August 30, 2019
Partial rescue of naturally occurring active site factor X variants through decreased inhibition by tissue factor pathway inhibitor and antithrombinJosefin Ahnström, Magdalena Gierula, Joseph Temenu, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 14, 2006
Effect of L-carnitine administration on erythrocyte survival in haemodialysis patientsArduino Arduini, Mario Bonomini, Elaine J Clutterbuck, et al.
The Lancet. Rheumatology|February 1, 2021
Thromboses and COVID-19: reducing inflammation in addition to thromboprophylaxisPuja Mehta, Dorian O Haskard, Michael A Laffan, et al.
Blood|April 21, 2012
O-linked glycosylation of von Willebrand factor modulates the interaction with platelet receptor glycoprotein Ib under static and shear stress conditionsAgata A Nowak, Kevin Canis, Anne Riddell, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|April 1, 2006
Antithrombin Nagasaki (Ser 116 to Pro): a rare antithrombin variant with abnormal heparin binding presenting during pregnancyJames S O'Ddonnell, Larry Hinkson, Andrew McCarthy, et al.
Intractable & Rare Diseases Research|May 20, 2016
Dietary supplement use and nosebleeds in hereditary haemorrhagic telangiectasia - an observational studyBasel Chamali, Helen Finnamore, Richard Manning, et al.
Fertility and Sterility|September 18, 2004
Thrombocythemia and hemoperitoneum after transvaginal oocyte retrieval for in vitro fertilizationSalem A El-Shawarby, Raul A Margara, Geoffrey H Trew, et al.
Pageof 6

Showing results (11-20 of 51) with videos related to

Sort By:
Pageof 6
British Journal of Haematology|February 14, 2002
Genotype at the secretor blood group locus is a determinant of plasma von Willebrand factor levelJames O'Donnell, Frank E Boulton, Richard A Manning, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|September 22, 2005
Low-density lipoprotein receptor-related protein polymorphisms in patients with elevated factor VIII coagulant activity and venous thrombosisNicholas Cunningham, Michael A Laffan, Richard A Manning, et al.
Blood|April 21, 2016
Inherited platelet disorders: toward DNA-based diagnosisClaire Lentaigne, Kathleen Freson, Michael A Laffan, et al.
Journal of Thrombosis and Haemostasis : JTH|August 30, 2019
Partial rescue of naturally occurring active site factor X variants through decreased inhibition by tissue factor pathway inhibitor and antithrombinJosefin Ahnström, Magdalena Gierula, Joseph Temenu, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 14, 2006
Effect of L-carnitine administration on erythrocyte survival in haemodialysis patientsArduino Arduini, Mario Bonomini, Elaine J Clutterbuck, et al.
The Lancet. Rheumatology|February 1, 2021
Thromboses and COVID-19: reducing inflammation in addition to thromboprophylaxisPuja Mehta, Dorian O Haskard, Michael A Laffan, et al.
Blood|April 21, 2012
O-linked glycosylation of von Willebrand factor modulates the interaction with platelet receptor glycoprotein Ib under static and shear stress conditionsAgata A Nowak, Kevin Canis, Anne Riddell, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|April 1, 2006
Antithrombin Nagasaki (Ser 116 to Pro): a rare antithrombin variant with abnormal heparin binding presenting during pregnancyJames S O'Ddonnell, Larry Hinkson, Andrew McCarthy, et al.
Intractable & Rare Diseases Research|May 20, 2016
Dietary supplement use and nosebleeds in hereditary haemorrhagic telangiectasia - an observational studyBasel Chamali, Helen Finnamore, Richard Manning, et al.
Fertility and Sterility|September 18, 2004
Thrombocythemia and hemoperitoneum after transvaginal oocyte retrieval for in vitro fertilizationSalem A El-Shawarby, Raul A Margara, Geoffrey H Trew, et al.
Pageof 6